MDL Track
MDL 2738
D.N.J.
Johnson & Johnson talcum powder products liability
67,115 pending
Pharmaceutical · claims alleging talc products contributed to ovarian cancer or mesothelioma
Defendant
Johnson & Johnson
MDL / Track
MDL 2738
D.N.J.
Judge
Judge Michael A. Shipp
Plaintiffs
roughly 67,135 pending claims (67,115 per JPML's March 2, 2026 report, plus ~20 new filings tracked since)
Bellwether / Trial
Settlement Status
Track litigations for free. Save this matter, capture notes, and monitor live signals.
Case overview
Johnson & Johnson has offered up to $5.5 billion to settle approximately 76,000 ovarian cancer claims, contingent on 95% claimant participation, after its third bankruptcy attempt failed in March 2025. MDL 2738 (In re Johnson & Johnson Talcum Powder Products Marketing, Sales Practices, and Products Liability Litigation) before Judge Michael A. Shipp in the District of New Jersey remains the largest active federal mass tort with roughly 68,000-69,000 pending cases as of mid-2026. Bellwether trials have produced split results: a $40 million plaintiff verdict in December 2025, a defense win in June 2026, and a $32 million mesothelioma verdict days later. J&J reports settling approximately 95% of filed mesothelioma cases individually outside the MDL.
Causation Theory
Plaintiffs advance dual causation theories. For mesothelioma: asbestos fibers contaminating talc deposits, with FDA testing detecting asbestos in approximately 15% of cosmetic powders between 2018-2022. For ovarian cancer: talc particles migrating through the female reproductive tract to the ovaries, causing chronic inflammation. The International Agency for Research on Cancer reclassified talc from Group 2B to Group 2A ("probably carcinogenic to humans") in July 2024, citing limited human evidence, sufficient animal evidence, and strong mechanistic data showing talc exhibits key carcinogenic characteristics in human cells. The March 2026 retraction of a 1977 Lancet commentary—long cited by defense—removed a historical safety claim from the literature.
Case Management Orders
Litigation status
MDL 2738 (In re Johnson & Johnson Talcum Powder Products Marketing, Sales Practices and Products Liability Litigation) remains before Judge Michael A. Shipp in D.N.J. On July 22, 2026, the court granted defendants' motion for an order to show cause why all pending claims should not be dismissed for inability to prove specific causation under Rule 702, after two key expert witnesses withdrew (2026 U.S. Dist. LEXIS 162870). On July 27, 2026, J&J proposed a $5.5 billion resolution of roughly 76,000 ovarian cancer claims conditioned on 95% claimant participation; the proposal does not cover mesothelioma claims.
MDL Track
MDL 2738
D.N.J.
Johnson & Johnson talcum powder products liability
67,115 pending
State Court Activity
Parallel state-court trials active in Florida, Texas, California, Missouri, Pennsylvania, New Jersey; mesothelioma claims litigated individually outside MDL 2738
MDL 2738 Leadership
Plaintiff Leadership
Co-Lead Counsel
Liaison Counsel
Executive Committee Member
Steering Committee Member
Sindhu S. Daniel
Baron & Budd, P.C.
Jeff S. Gibson
Cohen & Malad, LLP
Victoria Maniatis
Sanders Phillips Grossman, LLC
Geographic exposure
J&J's U.S. and Canadian talc-based Baby Powder sales ended May 2020; global talc sales ended 2023. FDA October 2019 testing confirmed chrysotile asbestos in single lot, prompting voluntary recall. IARC July 2024 reclassified talc as Group 2A ('probably carcinogenic to humans'). J&J proposed $5.5 billion settlement for ~76,000 ovarian-cancer claims conditional on 95% opt-in; mesothelioma claims excluded. Imerys Talc America §524(g) Trust ($862M–$1.45B range) in final bankruptcy negotiation for occupational and secondary exposure claims.
Historic R.T. Vanderbilt Co. and Gouverneur Talc Co. operations; ore contains 37–59% non-asbestiform tremolite plus asbestiform tremolite and anthophyllite fibers. NIOSH cohort documented excess mesothelioma; six mesothelioma deaths identified in Finkelstein reanalysis during 1990–2007. Primary U.S. site for talc-mining mesothelioma litigation.
Eastern Magnesia and Carey-Canada talc mining and processing; tremolite and actinolite contamination documented in NIOSH worker mortality cohort with respiratory disease elevations. Imerys Talc America successor operations continue at former Cyprus/Luzenac sites.
Imerys Talc America (successor to Cyprus Industrial Minerals/Luzenac) industrial talc mining and processing facility; tremolite-contaminated talc supplied to U.S. rubber, plastics, paint, ceramic, paper, friction-product, and personal-care industries.
Briggs Talc Mine (Death Valley Junction); USGS Van Gosen 2004 documented tremolite contamination in talc deposit. Part of broader California litigation hotspot with filings concentrated in Los Angeles, San Diego, and Alameda County.
Major battleground for ovarian cancer claims; Missouri Supreme Court upheld $2.12 billion verdict in Ingham v. Johnson & Johnson, Case No. SC98082 (Mo.), for twenty-two ovarian-cancer plaintiffs. Largest surviving talc verdict until 2025.
Johnson & Johnson headquarters state; MDL 2738 (Talcum Powder Products Liability Litigation) pending before U.S. District Judge Freda L. Wolfson. Central venue for consolidated cosmetic talc litigation.
Philadelphia Court of Common Pleas launched dedicated mass tort program for talcum powder lawsuits; bellwether trials scheduled for 2026. Rising filing volume for ovarian cancer and mesothelioma claims.
$25 million verdict ordered August 2025 for terminal peritoneal mesothelioma from lifelong J&J baby powder use; jury found negligence for asbestos-contaminated talc. Dr. Steve Mann deposition testimony confirmed he received asbestos test results but chose not to inform management or regulators.
$8 million verdict in 2025 for mesothelioma linked to talc use. Emerging plaintiff-favorable jurisdiction in New England corridor.
$260 million mesothelioma verdict upheld in 2024 for talc-caused mesothelioma. Pacific Northwest anchor for talc litigation with demonstrated jury willingness to award substantial damages.
Key defendants
Johnson & Johnson
Role: Original Manufacturer
Core defendant in MDL No. 2738 (D.N.J.). Special Master granted motion to add successor entities as defendants in Jan. 2024 (Dkt. No. 26636).
LTL Management LLC
Role: Bankruptcy Vehicle
North Carolina LLC created Oct. 2021 to assume Old JJCI's talc liabilities. Subject of fraudulent transfer litigation (Bynum v. LLT Management LLC, No. 3:24-cv-07065-MAS-RLS).
Red River Talc LLC
Role: Successor Entity
Texas LLC created Aug. 2024 restructuring; holds talc claims and pursuing Chapter 11 settlement. Over 60,000 plaintiffs asserting claims as of Sept. 2024.
Kenvue Inc.
Role: Successor Entity
Added as defendant in Second Amended Master Complaint per Special Master Order No. 17 (Dkt. No. 26636). Successor liability exposure under multi-state choice-of-law analysis.
Janssen Pharmaceuticals Inc.
Role: Affiliate Defendant
Added as defendant in SAMC; same successor liability posture as Kenvue. Limited direct talc product involvement.
Imerys Talc America Inc.
Role: Talc Supplier
Named in First Amended Master Complaint. Mining/defense exposure distinct from consumer products defendants.
| Defendant | Role | Intelligence Note |
|---|---|---|
| Johnson & Johnson | Original Manufacturer | Core defendant in MDL No. 2738 (D.N.J.). Special Master granted motion to add successor entities as defendants in Jan. 2024 (Dkt. No. 26636). |
| LTL Management LLC | Bankruptcy Vehicle | North Carolina LLC created Oct. 2021 to assume Old JJCI's talc liabilities. Subject of fraudulent transfer litigation (Bynum v. LLT Management LLC, No. 3:24-cv-07065-MAS-RLS). |
| Red River Talc LLC | Successor Entity | Texas LLC created Aug. 2024 restructuring; holds talc claims and pursuing Chapter 11 settlement. Over 60,000 plaintiffs asserting claims as of Sept. 2024. |
| Kenvue Inc. | Successor Entity | Added as defendant in Second Amended Master Complaint per Special Master Order No. 17 (Dkt. No. 26636). Successor liability exposure under multi-state choice-of-law analysis. |
| Janssen Pharmaceuticals Inc. | Affiliate Defendant | Added as defendant in SAMC; same successor liability posture as Kenvue. Limited direct talc product involvement. |
| Imerys Talc America Inc. | Talc Supplier | Named in First Amended Master Complaint. Mining/defense exposure distinct from consumer products defendants. |
Timeline
$4.69B Missouri Talc Verdict
St. Louis jury awards $4.69 billion to 22 women in ovarian cancer talc trial. Missouri Court of Appeals later reduces award to $2.12 billion for five Missouri plaintiffs, reversing as to 17 non-residents for lack of personal jurisdiction.
FDA Finds Asbestos in J&J Baby Powder
FDA testing detects chrysotile asbestos in lot #22318RB of Johnson's Baby Powder. J&J voluntarily recalls approximately 33,000 bottles. J&J discontinues North American talc sales in 2020.
First LTL Management Bankruptcy Filed
J&J creates LTL Management LLC and files Chapter 11, triggering automatic stay of approximately 38,000 lawsuits. Third Circuit dismisses in January 2023 for lack of good faith and financial distress.
IARC Upgrades Talc to Group 2A
International Agency for Research on Cancer reclassifies talc from Group 2B ('possibly carcinogenic') to Group 2A ('probably carcinogenic to humans'), including talc without asbestos contamination, based on limited human evidence, sufficient animal evidence, and strong mechanistic evidence.
Red River Talc Bankruptcy Dismissed
Judge Christopher Lopez, U.S. Bankruptcy Court for the Southern District of Texas, dismisses J&J's third bankruptcy attempt (Red River Talc LLC) in 57-page opinion, returning approximately 67,115 cases to MDL 2738 before Judge Michael A. Shipp in D.N.J. J&J announces it will not appeal or file again.
$1.56B Baltimore Mesothelioma Verdict
Baltimore jury awards $59.8 million compensatory and $1.5 billion punitive damages in Craft v. J&J for peritoneal mesothelioma plaintiff, largest individual talc award in history, now under appeal.
Daubert Ruling Admits Expert Testimony
Federal judge issues 658-page ruling allowing plaintiffs' expert witnesses to testify on talc-ovarian cancer link in MDL 2738, clearing major hurdle for bellwether trials.
J&J Announces $5.5 Billion Settlement
J&J agrees to pay $5.5 billion to resolve approximately 76,000 ovarian cancer claims, conditional on 95% opt-in rate, covering 99.75% of pending ovarian cancer cases in MDL 2738 and related state courts. Mesothelioma claims excluded.
Statute of limitations
MDL 2738 (In re: Johnson & Johnson Talcum Powder Products Marketing, Sales Practices and Products Liability Litigation) before Judge Michael A. Shipp in D.N.J. does not toll state statutes of limitations. J&J's third bankruptcy dismissal in early 2024 removed any stay on filings. As of January 6, 2026, 67,580 cases pending in MDL per source. No global settlement tolling agreement currently in effect—intake must screen by individual state SOL. Sources indicate statutes typically range 1–4 years from diagnosis or discovery, with wrongful death often shorter than personal injury.
California
2 years
Rule: Cal. Code Civ. Proc. § 335.1; discovery rule applies per sources
Discovery: Clock starts when plaintiff discovers or should have discovered injury and its cause; ovarian cancer diagnosis typically triggers
No pending revival statute identified in sources
Florida
4 years personal injury, 2 years wrongful death
Rule: Fla. Stat. § 95.11; discovery rule applies
Discovery: Clock begins when plaintiff knew or should have known of injury with reasonable diligence
Longest PI window among major states per source table; large plaintiff pool
New York
3 years personal injury, 2 years wrongful death
Rule: N.Y. C.P.L.R.; discovery rule applies
Discovery: Accrues upon discovery of injury and causal link
WD claims shorter than PI; significant state court filings per sources
Texas
2 years
Rule: Tex. Civ. Prac. & Rem. Code; discovery rule applies
Discovery: Accrues when plaintiff knows or should know of injury and cause
J&J bankruptcy maneuvers do not stay state SOL per sources
Pennsylvania
2 years
Rule: 42 Pa. Cons. Stat.; discovery rule applies
Discovery: Accrues when plaintiff knows or reasonably should know of injury and its cause
Active venue for talc filings per sources
New Jersey
2 years
Rule: N.J. Stat. Ann.; discovery rule applies
Discovery: Accrues upon discovery of injury and causal connection
MDL 2738 venued in D.N.J. but does not toll state SOL; state filings accelerating post-bankruptcy dismissal per January 2026 source
Illinois
2 years
Rule: 735 Ill. Comp. Stat.; discovery rule applies
Discovery: Accrues when plaintiff knows or reasonably should know of injury and its cause
Statute of repose may apply to older product use
Minnesota
4 years personal injury, 3 years wrongful death
Rule: Minn. Stat.; discovery rule applies
Discovery: Four-year filing period generally begins when illness is diagnosed per source
Longest PI SOL in Upper Midwest; WD shorter than PI per source
| State | SOL | Rule | Discovery Rule | Notes |
|---|---|---|---|---|
| California | 2 years | Cal. Code Civ. Proc. § 335.1; discovery rule applies per sources | Clock starts when plaintiff discovers or should have discovered injury and its cause; ovarian cancer diagnosis typically triggers | No pending revival statute identified in sources |
| Florida | 4 years personal injury, 2 years wrongful death | Fla. Stat. § 95.11; discovery rule applies | Clock begins when plaintiff knew or should have known of injury with reasonable diligence | Longest PI window among major states per source table; large plaintiff pool |
| New York | 3 years personal injury, 2 years wrongful death | N.Y. C.P.L.R.; discovery rule applies | Accrues upon discovery of injury and causal link | WD claims shorter than PI; significant state court filings per sources |
| Texas | 2 years | Tex. Civ. Prac. & Rem. Code; discovery rule applies | Accrues when plaintiff knows or should know of injury and cause | J&J bankruptcy maneuvers do not stay state SOL per sources |
| Pennsylvania | 2 years | 42 Pa. Cons. Stat.; discovery rule applies | Accrues when plaintiff knows or reasonably should know of injury and its cause | Active venue for talc filings per sources |
| New Jersey | 2 years | N.J. Stat. Ann.; discovery rule applies | Accrues upon discovery of injury and causal connection | MDL 2738 venued in D.N.J. but does not toll state SOL; state filings accelerating post-bankruptcy dismissal per January 2026 source |
| Illinois | 2 years | 735 Ill. Comp. Stat.; discovery rule applies | Accrues when plaintiff knows or reasonably should know of injury and its cause | Statute of repose may apply to older product use |
| Minnesota | 4 years personal injury, 3 years wrongful death | Minn. Stat.; discovery rule applies | Four-year filing period generally begins when illness is diagnosed per source | Longest PI SOL in Upper Midwest; WD shorter than PI per source |
Live intelligence
AI litigation brief
Talc remains late-stage / active trials with 154 current signals in the accepted feed.
Overview
MDL 2738 (In re Johnson & Johnson Talcum Powder Products Marketing, Sales Practices and Products Liability Litigation) remains before Judge Michael A. Shipp in D.N.J. On July 22, 2026, the court granted defendants' motion for an order to show cause why all pending claims should not be dismissed for inability to prove specific causation under Rule 702, after two key expert witnesses withdrew (2026 U.S. Dist. LEXIS 162870). On July 27, 2026, J&J proposed a $5.5 billion resolution of roughly 76,000 ovarian cancer claims conditioned on 95% claimant participation; the proposal does not cover mesothelioma claims.
Key developments
Trajectory
Court filings and press coverage are both active in MDL 2738, pointing to sustained litigation pressure rather than a one-off headline cycle. 6 live sources are contributing current context.
Editorial intelligence
MDL 2738 should stay on the lead docket watch because it is the primary consolidation vehicle for Talc.
Generated Sep 30, 2026, 10:00 AM UTC
154 events detected
Google News (127)
Chubb Insurance Units Sued Over Coverage for Talc Injury Cases - Bloomberg Law News
4 Tips On Expert Gatekeeping From J&J Talc Deal - Law360
Missouri Plaintiffs, Talc Companies Seek Stay Citing Possible Deal - Mealey's
The $5.5 Billion Decision: How Johnson & Johnson Chose to Walk Away From a Fight It Claims to Have Been Winning - lawnews.co.uk
Does IMAAVY’s Approval and Ongoing Talc Verdict Meaningfully Shift the Bull Case for Johnson & Johnson (JNJ)? - simplywall.st
J&J, others hit with $10M talc mesothelioma verdict - The Black Chronicle
J&J Faces New Lawsuits and Verdicts While Trying to Settle Cases - asbestos.com
Louisiana Family Receives $10 Million Verdict Against J&J, Co-Defendants - Mesothelioma Guide
Family Receives Judgment Against J&J, Others - Mesothelioma Guide
J&J loses attack on talc researchers, couldn’t prove malice - The Black Chronicle
A record-breaking deal could finally end years of legal battles over talc - Futura, le média qui explore le monde
Scientists beat Johnson & Johnson in fight over talc cancer research - Gulf News
Three scientists beat J&J's defamation suit over talc research - Reuters
Johnson & Johnson: 5.5 billion deal on the talc lawsuit - nss magazine
J&J Talc Unit Loses Libel Suit Over Flawed Cancer Study - Law360
J&J Talc Unit Loses Libel Claims Over Asbestos Health Study (1) - Bloomberg Law News
Minnesota Jury Awards $10.2 Million in Mesothelioma Talc Lawsuit - mesothelioma.com
Minnesota Jury Awards $10.2M in Mesothelioma Talc Lawsuit - Mesothelioma.com
$5.5B J&J talc deal could shrink California coordinated litigation - Daily Journal
Uniroyal & Vi-Jon File Chapter 11 Over Asbestos and Talc Claims - asbestos.com
Explainer-Can J&J finally put the talc litigation behind it? - AOL.com
Money talcs: Why J&J offered $5.5bn to end cancer cases - RTE.ie
Johnson & Johnson To Settle Baby Powder Lawsuit Over A Decade Later - aol.com
$5.5B Talc Settlement Offer May End Baby Powder Lawsuits - asbestos.com
Private-Label Body Powder Maker Files for Bankruptcy to Resolve Talc Lawsuits - WSJ
Vi-Jon files Chapter 11 bankruptcy to resolve legacy talc liabilities through $25M trust - The Business Journals
JNJ Stock Advances After Hours On $5.5B Proposal To Resolve Talc Litigation - Stocktwits
Missouri woman sues Johnson & Johnson, claims baby powder caused ovarian cancer - KCTV
Johnson & Johnson settlement: Does talcum powder really increase ovarian cancer risk? - The Indian Express
Beasley Allen Challenges Removal From Phila. Talc Litigation as Judge Defends Decision to Appeals Court - Law.com
Johnson & Johnson to pay out US$5.5bn in talc cancer case - News - The Chemical Engineer
Johnson & Johnson to pay out US$5.5bn in talc cancer case - The Chemical Engineer
J&J proposes $5.5 billion settlement deal for talc cancer lawsuits - chemistryworld.com
Beyond the US$5.5 billion settlement: what Johnson & Johnson’s talc litigation reveals about product liability - Lexology
Can J&J finally put the talc litigation behind it? - The Business Standard
Johnson & Johnson Proposes Comprehensive Settlement to End Ovarian Talc Litigation - Global Cosmetics News
Fear, science, and the law: If talc powder is unlikely to cause cancer and J&J was winning in court, why did it pay more than $5.5 billion to settle? - geneticliteracyproject.org
Johnson & Johnson (JNJ) Seeks $5.5 Billion Talc Lawsuit Settlement - Yahoo Finance
Johnson & Johnson agrees to pay billions in cancer lawsuit settlement - KTALnews.com
Johnson & Johnson offers US$5.5B to end ovarian cancer talc lawsuits - personalcareinsights.com
USA: Johnson & Johnson offers USD5.5b to settle talc powder lawsuits - Business and Human Rights Centre
Johnson & Johnson Agrees $5.5bn Settlement To End Baby Powder Cancer Lawsuits - Arise News
Critical Mass With Law.com’s Amanda Bronstad: Johnson & Johnson to Pay at Least $5.5B in Talc Settlement, Meta Begins Trial in Tennessee AG’s Consumer Case - Law.com
J&J's multi-billion-dollar lawsuit: Did India see cancer claims? Is talc banned? - India Today
J&J proposes $5.5B talc baby powder deal over cancer lawsuits - eMarketer
Johnson & Johnson lawsuit: J&J offers up to $5.5 billion to settle baby powder ovarian cancer suits - ABC7 Los Angeles
J&J Proposes $5.5Bn Settlement In Ovarian Talc Litigation - insights.citeline.com
J&J's Proposed $5.5B Settlement Aims to End Talc Litigation - Powder & Bulk Solids
Opinion | The Talc Jackpot Tort Turnaround - WSJ
SETTLEMENT AGREEMENTS—HOUSEHOLD PRODUCTS—Johnson & Johnson proposes $5.5 billion ovarian talc settlement - VitalLaw.com
Here’s how much Johnson & Johnson is offering to settle talc baby powder cancer claims - WSAZ
Johnson & Johnson offers up to $5.5 billion to settle baby powder cancer lawsuits - Gulf Coast News and Weather
J&J proposes $5.5B talc settlement - Endpoints News
Johnson & Johnson offers $5.5B to settle baby powder cancer lawsuits - Global News
Johnson & Johnson agrees to pay $5.5 billion in talc powder settlement - FOX 10 Phoenix
Johnson & Johnson offers $5.5B talc lawsuit settlement - NJBIZ
With $5.5B settlement offer, J&J could be on its way to resolving talc litigation - Fierce Pharma
J&J to Pay $5.5 Billion to Settle Talc-Related Cancer Claims - Bloomberg.com
J&J Aims to End 15-Year Talc Fight With $5.5 Billion Settlement - Bloomberg Law News
$5.5 billion settlement reached in long-running ovarian cancer lawsuit involving Alabama law firm - AL.com
Johnson & Johnson to pay $5.5B to resolve talc litigation - MassDevice
Johnson & Johnson commits $5.5bn to end remaining talc litigation - PMLiVE
Is talcum powder safe? Understanding cancer risks amid Johnson & Johnson lawsuit - The Telegraph
Johnson & Johnson proposes $5.5B settlement to resolve remaining talc litigation - Proactive financial news
Johnson & Johnson offers to pay up to $5.5 billion to settle baby powder lawsuit - gamereactor.eu
Johnson & Johnson's talc settlement ends one fight. The casualty market's bigger problem remains - Insurance Business
Is J&J approaching the end of its talc litigation hangover? - pharmaphorum
Cosmetics giant to pay billions in baby powder lawsuit settlements - independent.co.uk
Johnson and Johnson to pay out £4 billion settlement over talcum powder cancer claims - LADbible
Johnson & Johnson offers up to $5.5 billion to settle baby powder cancer lawsuits | CNN Business - CNN
Johnson & Johnson offers $5.5 billion settlement regarding talc lawsuits - News On 6
Johnson & Johnson settling talc baby powder lawsuits for $5.5 billion - qz.com
Johnson & Johnson announces US$5.5 billion settlement of talc lawsuits - CNA
Why Johnson & Johnson is paying $5.5 billion over baby powder lawsuits - The Indian Express
Johnson & Johnson announces $5.5 billion settlement of talc lawsuits - The Hindu
J&J's $5.5 Billion Talc Settlement Has a Catch: 95% of Plaintiffs Must Say Yes - The Legal Examiner
Johnson & Johnson is paying $5.5 billion to settle its baby powder cancer lawsuits - qz.com
$5.5B J&J talc deal could end decade-long legal battle - The Hill
Jim Cramer: J&J talc settlement is good for a stock that has so much going for it already - CNBC
Johnson & Johnson Offers $5.5 Billion Settlement For Talcum Powder Lawsuits - NDTV
Johnson & Johnson settlement nets payments for thousands - NJ.com
Johnson & Johnson proposes $5.5 billion talc settlement to end marathon legal fight - AP News
Johnson & Johnson to pay $5.5bn settlement in talc cancer lawsuit - The Guardian
Johnson & Johnson offers up to $5.5bn to settle baby powder lawsuits - BBC
Johnson & Johnson agrees to pay $5.5B to settle talc lawsuits - Fox Business
J&J reaches sweeping talc deal that could end decade of litigation - Reuters
Johnson & Johnson reaches proposed $5.5B talcum powder settlement - upi.com
Johnson & Johnson offers $5.5 billion to settle talc lawsuits - cbsnews.com
Johnson & Johnson to pay $5.5 billion to settle baby powder cancer lawsuits - India Today
J&J offers $5.5bn to settle baby powder lawsuits - Sky News
Johnson & Johnson offers $5.5bn to settle talc cancer lawsuits - Al Jazeera
J&J, Ovarian Cancer Talc Claimants Unveil $5.5B Global Deal - law360.com
J&J announces $5.5bn settlement of talc lawsuits - RTE.ie
Johnson & Johnson reaches proposed $5.5B settlement to resolve talc lawsuits tied to ovarian cancer claims - aa.com.tr
Johnson & Johnson reaches proposed $5.5B settlement to resolve talc lawsuits tied to ovarian cancer claims - Anadolu Ajansı
Johnson & Johnson announces US$5.5bil settlement of talc lawsuits - Free Malaysia Today
Johnson & Johnson Settles 76,000 Talcum Powder Lawsuits for at Least $5.5B - Law.com
Johnson & Johnson announces $5.5 billion settlement of talc lawsuits - Yahoo! Finance Canada
Johnson & Johnson Announces a Proposed Resolution of Ovarian Talc Litigation - Business Wire
Johnson & Johnson to pay $5.5-billion settlement in baby powder lawsuits - The Globe and Mail
US pharma giant to pay out $7.9 billion over baby powder lawsuits - ABC News & Headlines – Australian Broadcasting Corporation
Johnson & Johnson to pay up to $5.5B to settle talc lawsuits (JNJ:NYSE) - Seeking Alpha
Johnson & Johnson to pay $5.5bn to settle US talcum powder lawsuit - Financial Times
Johnson & Johnson Agrees to Pay $5.5 Billion to Settle Talc Lawsuits - WSJ
Illinois Court Upholds $45 Million Judgment Against Johnson & Johnson - Mesothelioma Guide
Massive J&J Talc Powder Case Moves Towards Finale - lawstreetmedia.com
Judge questions evidence behind 69,000 Johnson & Johnson talc lawsuits - The Jersey Vindicator
Federal Judge Casts Doubt on 69,000 Cases Alleging J&J Talc Caused Cancer - Insurance Journal
Massive Awards in J&J Mesothelioma Talc Lawsuits as New Cases Filed - The Legal Examiner
US judge casts doubt on 69,000 cases alleging J&J talc caused cancer - Free Malaysia Today
J&J Talc Plaintiffs Must Back Up Cancer Link Or Risk MDL - Law360
Johnson & Johnson Wins Big: Federal Judge Orders Nearly 70,000 Talc Claimants to Show Why They Shouldn't be Dismissed - Law.com
After Disqualifying Beasley Allen, Johnson & Johnson Sets Sights on Other Talc Lawyers - Law.com
Court OKs $45M verdict in talc asbestos case, including $30M for ‘reduced lifespan’ - The Black Chronicle
'Stunning Turn of Events': Johnson & Johnson Asks Judge to Order Potential Dismissal of All 67,000 Talc Lawsuits - Law.com
Retired judge urges federal court to reject key talc researcher’s testing - The Black Chronicle
Johnson & Johnson (JNJ) Stock May Be Reasonable After Talc Verdict Ruling - Yahoo Finance
Can Johnson & Johnson (JNJ) Trade At A Discount Despite Talc Risk? - simplywall.st
Ill. Appeals Court Upholds $45M Talc Verdict Against J&J - Law360
Johnson & Johnson (JNJ) Faces Upheld $45 Million Talc Verdict In Illinois - simplywall.st
Johnson & Johnson (JNJ) Faces Fresh Talc Risk After $45 Million Verdict Stands - Yahoo Finance
Johnson's talcum powder found in Adamstown cupboard to be tested for asbestos - Newcastle Herald
Pa. Superior Court Upholds J&J Win In Talc Cancer Suit - Law360
Scottish court approves group legal action against Johnson & Johnson over talcum powder - Global Cosmetics News
Johnson & Johnson (JNJ) Has a Diversified Earnings Engine Bigger Than Talc - AlphaStreet
Court approves Scottish group action over Johnson & Johnson baby powder - Scottish Legal News
Why Minerals Technologies (MTX) Is Down 6.7% After Establishing a US$450 Million Talc Injury Trust - Sahm
Journal of hazardous materials • Turci F • PMID 42679572 • Journal Article.
Annals of work exposures and health • Cherrie JW • PMID 42647602 • Journal Article.
Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology • O'Brien KM • PMID 42578967 • Journal Article.
Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer • Yu H • PMID 42552036 • Editorial.
Annals of work exposures and health • Mischler SE • PMID 42497380 • Journal Article.
No recent FDA signals. Monitoring is active — this section updates automatically.
Johnson & Johnson Talcum Powder Products Marketing, Sales Practices and Products Liability Litigation
PACER docket filed in JPML: The plaintiffs are suing Johnson & Johnson and associated entities, alleging that their talcum powder products, specifically Johnson & Johnson’s Baby Powder and Shower to Shower, were defective and caused various injuries. These injuries include personal and economic losses, as well as physical and
Johnson & Johnson Talcum Powder Products Marketing, Sales Practices and Products Liability Litigation
PACER docket entry from NJD: COMPLAINT against JANSSEN PHARMACEUTICALS, INC., JOHNSON & JOHNSON, JOHNSON & JOHNSON CONSUMER, INC., JOHNSON & JOHNSON HOLDCO (NA) INC., KENVUE, INC., RED RIVER TALC, LLC ( Filing and Admin fee $ 405 receipt number ANJDC-17997534) with JURY DEMAND, filed by RITA FRANCES BLANCHARD. (Attachments: # 1
Johnson & Johnson Talcum Powder Products Marketing, Sales Practices and Products Liability Litigation
PACER docket entry from NJD: COMPLAINT against JANSSEN PHARMACEUTICALS, INC., JOHNSON & JOHNSON, JOHNSON & JOHNSON CONSUMER, INC., JOHNSON & JOHNSON HOLDCO (NA) INC., KENVUE, INC., RED RIVER TALC, LLC ( Filing and Admin fee $ 405 receipt number ANJDC-17997356) with JURY DEMAND, filed by SANDRA BANNING. (Attachments: # 1 Civil C
Johnson & Johnson Talcum Powder Products Marketing, Sales Practices and Products Liability Litigation
PACER docket entry from NJD: COMPLAINT against JANSSEN PHARMACEUTICALS, INC., JOHNSON & JOHNSON, JOHNSON & JOHNSON CONSUMER, INC., JOHNSON & JOHNSON HOLDCO (NA) INC., KENVUE, INC., RED RIVER TALC, LLC ( Filing and Admin fee $ 405 receipt number ANJDC-17996980) with JURY DEMAND, filed by MARTHA ARELLANO. (Attachments: # 1 Civil
Johnson & Johnson Talcum Powder Products Marketing, Sales Practices and Products Liability Litigation
PACER docket entry from NJD: COMPLAINT against JANSSEN PHARMACEUTICALS, INC., JOHNSON & JOHNSON, JOHNSON & JOHNSON HOLDCO (NA) INC. (NEW JJCI), KENVUE, INC., RED RIVER TALC LLC ( Filing and Admin fee $ 405 receipt number ANJDC-17995317) with JURY DEMAND, filed by KAREN HAZELTON. (Attachments: # 1 Civil Cover Sheet)(GOLDENBERG,
Johnson & Johnson Talcum Powder Products Marketing, Sales Practices and Products Liability Litigation
PACER docket entry from NJD: COMPLAINT against JANSSEN PHARMACEUTICALS, INC., JOHNSON & JOHNSON, JOHNSON & JOHNSON CONSUMER, INC., JOHNSON & JOHNSON HOLDCO (NA) INC., KENVUE, INC., RED RIVER TALC, LLC ( Filing and Admin fee $ 405 receipt number ANJDC-17985617) with JURY DEMAND, filed by DAWN GIBSON. (Attachments: # 1 Civil Cove
Johnson & Johnson Talcum Powder Products Marketing, Sales Practices and Products Liability Litigation
PACER docket entry from NJD: COMPLAINT against JANSSEN PHARMACEUTICALS, INC., JOHNSON & JOHNSON, JOHNSON & JOHNSON CONSUMER, INC., JOHNSON & JOHNSON HOLDCO (NA) INC., KENVUE, INC., RED RIVER TALC, LLC ( Filing and Admin fee $ 405 receipt number ANJDC-17985463) with JURY DEMAND, filed by LEROY PITTS, JR. (Attachments: # 1 Civil
Johnson & Johnson Talcum Powder Products Marketing, Sales Practices and Products Liability Litigation
PACER docket entry from NJD: COMPLAINT against JANSSEN PHARMACEUTICALS, INC., JOHNSON & JOHNSON, JOHNSON & JOHNSON CONSUMER INC., JOHNSON & JOHNSON HOLDCO (NA) INC., KENVUE, INC., LLT MANAGEMENT, LLC F/K/A LTL MANAGEMENT, LLC, RED RIVER LLC ( Filing and Admin fee $ 405 receipt number ANJDC-17969355) with JURY DEMAND, filed by S
Johnson & Johnson Talcum Powder Products Marketing, Sales Practices and Products Liability Litigation
PACER docket entry from NJD: COMPLAINT against JANSSEN PHARMACEUTICALS, INC., JOHNSON & JOHNSON, JOHNSON & JOHNSON CONSUMER INC., JOHNSON & JOHNSON HOLDCO (NA) INC., KENVUE, INC., LLT MANAGEMENT, LLC F/K/A LTL MANAGEMENT, LLC, RED RIVER LLC ( Filing and Admin fee $ 405 receipt number ANJDC-17969330) with JURY DEMAND, filed by J
Johnson & Johnson Talcum Powder Products Marketing, Sales Practices and Products Liability Litigation
PACER docket entry from NJD: COMPLAINT against JANSSEN PHARMACEUTICALS, INC., JOHNSON & JOHNSON, JOHNSON & JOHNSON CONSUMER INC., JOHNSON & JOHNSON HOLDCO (NA) INC., KENVUE, INC., LLT MANAGEMENT, LLC F/K/A LTL MANAGEMENT, LLC, RED RIVER LLC ( Filing and Admin fee $ 405 receipt number ANJDC-17969303) with JURY DEMAND, filed by R
Workbench
Sign in to save litigations, capture notes, and monitor live signals. Sign in for unlimited.
LexGenius Ranking
82Score
Court, news, and regulatory activity are elevated
Monitoring
Live
monitoring
Last: Sep 30, 2026, 10:00 AM UTC
Next: —
Source Monitoring
PACER
PACER
Google News
FAERS
PubMed
Event feed
154
events detected
AI Brief
Talc remains late-stage / active trials with 154 current signals in the accepted feed.
Overview
MDL 2738 (In re Johnson & Johnson Talcum Powder Products Marketing, Sales Practices and Products Liability Litigation) remains before Judge Michael A. Shipp in D.N.J. On July 22, 2026, the court granted defendants' motion for an order to show cause why all pending claims should not be dismissed for inability to prove specific causation under Rule 702, after two key expert witnesses withdrew (2026 U.S. Dist. LEXIS 162870). On July 27, 2026, J&J proposed a $5.5 billion resolution of roughly 76,000 ovarian cancer claims conditioned on 95% claimant participation; the proposal does not cover mesothelioma claims.
Key developments
PACER court filing on Dec 31: Johnson & Johnson Talcum Powder Products Marketing, Sales Practices and Products Liability Litigation. ‖ Bloomberg Law News news on Sep 28: Chubb Insurance Units Sued Over Coverage for Talc Injury Cases - Bloomberg Law News. ‖ PubMed research on Aug 27: Quantitative classification of asbestos-like morphology for assessing potentially hazardous fibrous minerals..
Generated Sep 30, 2026, 10:00 AM UTC
Tracked MDLs
MDL 2738
D.N.J.
Johnson & Johnson talcum powder products liability